Literature DB >> 11167992

Patients with inflammatory bowel disease (IBD) reveal increased induction capacity of intracellular interferon-gamma (IFN-gamma) in peripheral CD8+ lymphocytes co-cultured with intestinal epithelial cells.

G Bisping1, N Lügering, S Lütke-Brintrup, H G Pauels, G Schürmann, W Domschke, T Kucharzik.   

Abstract

Intestinal epithelial cells seem to play a key role during IBD. The network of cellular interactions between epithelial cells and lamina propria mononuclear cells is still incompletely understood. In the following co-culture model we investigated the influence of intestinal epithelial cells on cytokine expression of T cytotoxic and T helper cells from patients with IBD and healthy controls. Peripheral blood mononuclear cells (PBMC) were purified by a Ficoll-Hypaque gradient followed by co-incubation with epithelial cells in multiwell cell culture insert plates in direct contact as well as separated by transwell filters. We used Caco-2 cells as well as freshly isolated colonic epithelia obtained from surgical specimens. Three-colour immunofluorescence flow cytometry was performed after collection, stimulation and staining of PBMC with anti-CD4, anti-CD8, anti-IFN-gamma and anti-IL-4. Patients with IBD (Crohn's disease (CD), n = 12; ulcerative colitis (UC), n = 16) and healthy controls (n = 10) were included in the study. After 24 h of co-incubation with Caco-2 cells we found a significant increase of IFN-gamma-producing CD8+ lymphocytes in patients with IBD. In contrast, healthy controls did not respond to the epithelial stimulus. No significant differences could be found between CD and UC or active and inactive disease. A significant increase of IFN-gamma+/CD8+ lymphocytes in patients with UC was also seen after direct co-incubation with primary cultures of colonic crypt cells. The observed epithelial-lymphocyte interaction seems to be MHC I-restricted. No significant epithelial cell-mediated effects on cytokine expression were detected in the PBMC CD4+ subsets. Patients with IBD-even in an inactive state of disease-exert an increased capacity for IFN-gamma induction in CD8+ lymphocytes mediated by intestinal epithelial cells. This mechanism may be important during chronic intestinal inflammation, as in the case of altered mucosal barrier function epithelial cells may become targets for IFN-gamma-producing CD8+ lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11167992      PMCID: PMC1905965          DOI: 10.1046/j.1365-2249.2001.01443.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  39 in total

1.  Defective expression of gp180, a novel CD8 ligand on intestinal epithelial cells, in inflammatory bowel disease.

Authors:  L S Toy; X Y Yio; A Lin; S Honig; L Mayer
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

2.  Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10.

Authors:  T Kucharzik; N Lügering; H Weigelt; M Adolf; W Domschke; R Stoll
Journal:  Clin Exp Immunol       Date:  1996-06       Impact factor: 4.330

Review 3.  Inflammatory bowel disease: etiology and pathogenesis.

Authors:  C Fiocchi
Journal:  Gastroenterology       Date:  1998-07       Impact factor: 22.682

4.  Interactions between peripheral blood CD8 T lymphocytes and intestinal epithelial cells (iEC).

Authors:  F A Arosa; C Irwin; L Mayer; M de Sousa; D N Posnett
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

5.  A mucosal intranet: intestinal epithelial cells down-regulate intraepithelial, but not peripheral, T lymphocytes.

Authors:  M Yamamoto; K Fujihashi; K Kawabata; J R McGhee; H Kiyono
Journal:  J Immunol       Date:  1998-03-01       Impact factor: 5.422

6.  Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with active inflammatory bowel disease.

Authors:  S Müller; J Lory; N Corazza; G M Griffiths; K Z'graggen; L Mazzucchelli; A Kappeler; C Mueller
Journal:  Am J Pathol       Date:  1998-01       Impact factor: 4.307

Review 7.  Cytokine flow cytometry: understanding cytokine biology at the single-cell level.

Authors:  C Prussin
Journal:  J Clin Immunol       Date:  1997-05       Impact factor: 8.317

Review 8.  Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases.

Authors:  R B Sartor
Journal:  Am J Gastroenterol       Date:  1997-12       Impact factor: 10.864

9.  Interleukin 12 is expressed and actively released by Crohn's disease intestinal lamina propria mononuclear cells.

Authors:  G Monteleone; L Biancone; R Marasco; G Morrone; O Marasco; F Luzza; F Pallone
Journal:  Gastroenterology       Date:  1997-04       Impact factor: 22.682

10.  In vitro studies of ulcerative colitis. II. Cytotoxic action of white blood cells from patients on human fetal colon cells.

Authors:  P PERLMANN; O BROBERGER
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307

View more
  23 in total

1.  Regulation of alpha1-proteinase inhibitor release by proinflammatory cytokines in human intestinal epithelial cells.

Authors:  D Faust; K Raschke; S Hormann; V Milovic; J Stein
Journal:  Clin Exp Immunol       Date:  2002-05       Impact factor: 4.330

2.  Experimental colitis is associated with transcriptional inhibition of Na+/Ca2+ exchanger isoform 1 (NCX1) expression by interferon γ in the renal distal convoluted tubules.

Authors:  Vijayababu M Radhakrishnan; Pawel Kojs; Rajalakshmy Ramalingam; Monica T Midura-Kiela; Peter Angeli; Pawel R Kiela; Fayez K Ghishan
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

3.  Increased expression of interleukin 17 in inflammatory bowel disease.

Authors:  S Fujino; A Andoh; S Bamba; A Ogawa; K Hata; Y Araki; T Bamba; Y Fujiyama
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

4.  Inflammatory Responses of Porcine MoDC and Intestinal Epithelial Cells in a Direct-Contact Co-culture System Following a Bacterial Challenge.

Authors:  Henriette Loss; Jörg R Aschenbach; Friederike Ebner; Karsten Tedin; Ulrike Lodemann
Journal:  Inflammation       Date:  2020-04       Impact factor: 4.092

5.  Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia.

Authors:  Lillian Maggio-Price; Helle Bielefeldt-Ohmann; Piper Treuting; Brian M Iritani; Weiping Zeng; Andrea Nicks; Mark Tsang; Donna Shows; Phil Morrissey; Joanne L Viney
Journal:  Am J Pathol       Date:  2005-06       Impact factor: 4.307

Review 6.  Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?

Authors:  Franco Scaldaferri; Carmen Correale; Antonio Gasbarrini; Silvio Danese
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

7.  T- and B-cell immune responses of patients who had undergone colectomies to oral administration of Salmonella enterica serovar Typhi Ty21a vaccine.

Authors:  Jan Kilhamn; Samuel B Lundin; Hans Brevinge; Ann-Mari Svennerholm; Marianne Jertborn
Journal:  Clin Diagn Lab Immunol       Date:  2003-05

8.  Gene expression profile after peroxisome proliferator activator receptor-gamma ligand administration in dextran sodium sulfate mice.

Authors:  Atsushi Nakajima; Koichiro Wada; Kazufumi Katayama; Lawrence Saubermann; Emi Osawa; Hajime Nagase; Norio Ueno; Nobuyuki Matsuhashi; Hiroyuki Aburatani
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

9.  A method for high purity intestinal epithelial cell culture from adult human and murine tissues for the investigation of innate immune function.

Authors:  Christina L Graves; Scott W Harden; Melissa LaPato; Michael Nelson; Byron Amador; Heather Sorenson; Charles J Frazier; Shannon M Wallet
Journal:  J Immunol Methods       Date:  2014-09-02       Impact factor: 2.303

10.  Inflammatory bowel diseases influence major histocompatibility complex class I (MHC I) and II compartments in intestinal epithelial cells.

Authors:  F Bär; C Sina; G Hundorfean; R Pagel; H Lehnert; K Fellermann; J Büning
Journal:  Clin Exp Immunol       Date:  2013-05       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.